Jacques Bruhwyler

2PUBLICATIONS
6CO-AUTHORS
OtorhinolaryngologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 12, 2026
Phase 1, first-in-human, randomized, placebo-controlled, dose-escalating study to evaluate OVX033, a nucleocapsid-based SARS-CoV-2 candidate vaccine.

|Jun 27, 2025
Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine.

Nicola Groth, Jacques Bruhwyler, Jessika Tourneur

Pageof 1

Frequent Collaborators

1 joint publications

Olivia Bonduelle

1 joint publications

Liem Binh Luong

1 joint publications

Michèle Wokam

1 joint publications

Thalia Garcia Téllez